Ligands

Details for Australian Patent Application No. 2004276061 (hide)

Owner AstraZeneca AB

Inventors Gordon, John; McCarthy, Dennis J; Phillips, Eifion; Keith, Richard A; Heys, John Richard; Smith, Mark A; Dorff, Peter

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004276061

PCT Pub. Number WO2005/030778

Priority 60/505,731 25.09.03 US

Filing date 24 September 2004

Wipo publication date 7 April 2005

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/030778 Priority application(s): WO2005/030778

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276062-Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

2004276055-Quinazoline derivatives